BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30124483)

  • 1. Do we need biomarkers for the follow-up and shortening of antibiotic treatment duration?
    Dianti M; Luna CM
    Curr Opin Crit Care; 2018 Oct; 24(5):361-369. PubMed ID: 30124483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic efficacy of serum procalcitonin, C-reactive protein concentration and clinical pulmonary infection score in Ventilator-Associated Pneumonia.
    Chen C; Yan M; Hu C; Lv X; Zhang H; Chen S
    Med Sci (Paris); 2018 Oct; 34 Focus issue F1():26-32. PubMed ID: 30403171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New guidelines for hospital-acquired pneumonia/ventilator-associated pneumonia: USA vs. Europe.
    Martin-Loeches I; Rodriguez AH; Torres A
    Curr Opin Crit Care; 2018 Oct; 24(5):347-352. PubMed ID: 30063491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pulmonary infection score and a spot serum procalcitonin level to guide discontinuation of antibiotics in ventilator-associated pneumonia: a study in a single institution with high prevalence of nonfermentative gram-negative bacilli infection.
    Wongsurakiat P; Tulatamakit S
    Ther Adv Respir Dis; 2018; 12():1753466618760134. PubMed ID: 29506460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein and procalcitonin profile in ventilator-associated lower respiratory infections.
    Coelho L; Rabello L; Salluh J; Martin-Loeches I; Rodriguez A; Nseir S; Gomes JA; Povoa P;
    J Crit Care; 2018 Dec; 48():385-389. PubMed ID: 30308469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic treatment of hospital-acquired pneumonia: is it different from ventilator-associated pneumonia?
    Niederman MS
    Curr Opin Crit Care; 2018 Oct; 24(5):353-360. PubMed ID: 30028739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin and C-reactive protein perform better than the neutrophil/lymphocyte count ratio in evaluating hospital acquired pneumonia.
    Zheng N; Zhu D; Han Y
    BMC Pulm Med; 2020 Jun; 20(1):166. PubMed ID: 32527243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT).
    Torres A; Niederman MS; Chastre J; Ewig S; Fernandez-Vandellos P; Hanberger H; Kollef M; Li Bassi G; Luna CM; Martin-Loeches I; Paiva JA; Read RC; Rigau D; Timsit JF; Welte T; Wunderink R
    Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28890434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of procalcitonin in ventilator-associated pneumonia.
    Corbacho Re MF; Rocchetti NS; Settecase CJ; Bagilet DH
    Med Clin (Barc); 2019 Mar; 152(6):216-221. PubMed ID: 30154009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procalcitonin as a biomarker for ventilator associated pneumonia in COVID-19 patients: Is it an useful stewardship tool?
    Côrtes MF; de Almeida BL; Espinoza EPS; Campos AF; do Nascimento Moura ML; Salomão MC; Boszczowski I; Freire MP; de Carvalho LB; Paranhos-Baccalà G; Costa SF; Guimarães T
    Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115344. PubMed ID: 34243136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
    Werarak P; Kiratisin P; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging trends of nosocomial pneumonia in intensive care unit of a tertiary care public teaching hospital in Western India.
    Bhadade R; Harde M; deSouza R; More A; Bharmal R
    Ann Afr Med; 2017; 16(3):107-113. PubMed ID: 28671150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predictive value of procalcitonin in ventilator-associated pneumonia after cardiac valve replacement.
    Song YY; Zhang B; Gu JW; Zhang YJ; Wang Y
    Scand J Clin Lab Invest; 2020 Sep; 80(5):423-426. PubMed ID: 32425062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung Ultrasound Combined With Procalcitonin for a Diagnosis of Ventilator-Associated Pneumonia.
    Zhou J; Song J; Gong S; Hu W; Wang M; Xiao A; Zhang C; Dong Z
    Respir Care; 2019 May; 64(5):519-527. PubMed ID: 30670664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management.
    Barbier F; Andremont A; Wolff M; Bouadma L
    Curr Opin Pulm Med; 2013 May; 19(3):216-28. PubMed ID: 23524477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults.
    Pugh R; Grant C; Cooke RP; Dempsey G
    Cochrane Database Syst Rev; 2011 Oct; (10):CD007577. PubMed ID: 21975771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locally derived versus guideline-based approach to treatment of hospital-acquired pneumonia in the trauma intensive care unit.
    Becher RD; Hoth JJ; Rebo JJ; Kendall JL; Miller PR
    Surg Infect (Larchmt); 2012 Dec; 13(6):352-9. PubMed ID: 23268613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin-Guided Antibiotic Discontinuation Might Shorten the Duration of Antibiotic Treatment Without Increasing Pneumonia Recurrence.
    Akagi T; Nagata N; Wakamatsu K; Harada T; Miyazaki H; Takeda S; Ushijima S; Aoyama T; Yoshida Y; Yatsugi H; Wada K; Ueda Y; Fujita M; Watanabe K
    Am J Med Sci; 2019 Jul; 358(1):33-44. PubMed ID: 31084909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiogical data, but not procalcitonin improve the accuracy of the clinical pulmonary infection score.
    Jung B; Embriaco N; Roux F; Forel JM; Demory D; Allardet-Servent J; Jaber S; La Scola B; Papazian L
    Intensive Care Med; 2010 May; 36(5):790-8. PubMed ID: 20217042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
    Sridharan P; Chamberlain RS
    Surg Infect (Larchmt); 2013 Dec; 14(6):489-511. PubMed ID: 24274059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.